News

BioTaiwan 2018 will take place in the Taipei Nangang Exhibition Center and CTBC Financial Park on July 18 to July 22. BioTaiwan 2018 is made up of 5 events, including the BioBusiness Asia Conference, Greater China & Asia-Pacific Opportunities Conference, Company Presentations, BioTaiwan Exhibition and One-on-one Partnering. This international conference has become a key event for Taiwan’s biotechnology industry.

Amaran Biotechnology, Inc. has been awarded cGMP certification from the Taiwan Food and Drug Administration (TFDA). The certificate demonstrates that Amaran Biotechnology manufactures and maintains a level of compliance in accordance with the Pharmaceutical Inspection Convention/Co-Operation Scheme (PIC/s) Guide to Good Manufacturing Practice (GMP). Its scope covers the manufacture of active pharmaceutical ingredients (API) at Amaran’s manufacturing facility, which is located in Hsinchu Biomedical Science Park.

Amaran Biotechnology, Inc., a biopharmaceuticals manufacturer and leading manufacturer of a key protein utilized in immunotherapy development pipelines Stellar Biotechnologies, Inc. (Nasdaq: SBOT), have entered into an exclusive multi-year supply agreement in connection with clinical development studies of immunotherapies for metastatic breast cancer and other cancers.